Carmichael Hill & Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$45.3K Buy
483
+92
+24% +$7.72K 0.02% 382
2024
Q2
$30.5K Hold
391
0.01% 421
2024
Q1
$35.5K Sell
391
-9
-2% -$749 0.01% 399
2023
Q4
$30.9K Sell
400
-63
-14% -$4.41K 0.01% 417
2023
Q3
$31.5K Sell
463
-56
-11% -$4.07K 0.01% 401
2023
Q2
$42.2K Sell
519
-62
-11% -$4.95K 0.02% 363
2023
Q1
$47.7K Buy
+581
New +$41.5K 0.02% 335

Other funds holding GEHC

Carmichael Hill & Associates's GEHC Position: Q3 2024 in Review

Carmichael Hill & Associates increased its GE HealthCare (GEHC) stake by 24% in Q3 2024, buying an estimated $7.72K and bringing the position to 483 shares worth $45.3K. The position accounts for 0.02% of the portfolio, ranked #382.

Carmichael Hill & Associates first reported a position in GEHC in Q1 2023 and has held it in 7 quarters since. The position peaked at $47.7K in Q1 2023. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q3 2024.

  • Carmichael Hill & Associates held 483 shares of GE HealthCare worth $45.3K as of Q3 2024.
  • Carmichael Hill & Associates bought 92 GE HealthCare shares in Q3 2024, an estimated $7.72K.
  • GE HealthCare made up 0.02% of Carmichael Hill & Associates's portfolio in Q3 2024, its #382 holding.
  • Carmichael Hill & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 7 quarters since.
  • Carmichael Hill & Associates's GE HealthCare position peaked at $47.7K in Q1 2023.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.